Definitive Contract HHSN261200511005C
- Not listed
- <p>The National Cancer Institute awarded a purchase order to Duke University for $10,000.00 on July 26, 2017, for analysis services. The order carried no set-aside designation and was priced on a firm fixed price basis. Work is performed at Duke's Office of Research Administration in Rockville, Maryland. The order is due for completion by August 30, 2018.</p>
- <p>The National Cancer Institute issued a purchase order to Duke University valued at $3,360.05 on September 26, 2013, for training and tuition services. Performance is located in Durham, North Carolina. The order is firm fixed price with an ultimate completion date of September 30, 2013.</p>
- This is a federal contract award from the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of California, Davis (UC Davis) for early-stage therapeutic development with a focus on Phase II clinical trials. The $34,176,737.26 definitive cost-reimbursement contract was awarded on January 1, 2006 with a period of performance through February 20, 2015. The contract did not have a small business set-aside. UC Davis, a major public research...
- This federal contract award was granted by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Duke University, a private university and non-profit organization. The $105,506.22 firm fixed-price purchase order is for a study or assessment, with a period of performance ending on May 1, 2017. The contract does not have a set-aside designation. Duke University has a robust track record of receiving federal contracts and grants from agencies such as the National...
- This federal contract award was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Duke University. The $2,839,159.48 cost-reimbursable contract supports research and development in the biomedical (applied research/exploratory development) domain. The contract does not have a set-aside designation. Duke University's Office of Research Administration Division is the prime contractor, and the work will be performed in Durham, North Carolina....
- The National Cancer Institute (NCI) awarded a $10,586.28 firm fixed-price purchase order contract to Duke University to provide viral load assays to evaluate the levels of virus in macaques enrolled in vaccine studies. The contract has a completion date of July 7, 2025, and was awarded on July 8, 2024. Duke University's Office of Research Administration Division will be the prime contractor, and there is no set-aside designation for this award. This contract aligns with Duke's expertise in...
- This is a $98,000 firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency, to Duke University. The contract is for services to quantify various chemical compounds in urine and blood samples, including amino-PAHs, OH-PHEs, creatinine, cotinine, and nitro-PAH-HGB adducts. The contract has a completion date of September 20, 2017 and was awarded on September 21, 2016. Duke University, a private university, is serving as the prime contractor for this...
- The U.S. government awarded Duke University, a private non-profit educational institution, a $2,359,896.00 cost-no-fee definitive contract for biomedical (applied/exploratory) research and development services. This contract does not have a set-aside designation. Duke University's Office of Research Administration Division is serving as the prime contractor. The contract was awarded on September 17, 2003 with a completion date of April 30, 2005. This award is not associated with a larger...
- This is a $34,230,792 delivery order contract awarded to Duke University by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, for an External Quality Assurance Program Oversight Laboratory (EQAPOL). The contract has a period of performance through September 29, 2031 and does not have a set-aside designation. Duke University is a prestigious private research institution that consistently secures federal contracts and grants, particularly from agencies like...
- This is a delivery order contract awarded under the NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery/indefinite quantity (IDIQ) contract. The contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, for the recovery of tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program. This work is funded through the American Recovery and Reinvestment Act (ARRA). The contract was...
This is a federal contract award from the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Duke University's Office of Research Administration Division. The contract, valued at $19,856,652.14, is for the provision of the Cancer Information Service. The contract does not have a set-aside designation. Duke University serves as the prime contractor for this definitive, cost-no-fee contract, which has an ultimate completion date of January 14, 2010. The contract demonstrates Duke's capabilities in providing a diverse array of services to federal agencies, including clinical research, biomedical studies, and other research and development projects, through both prime and subcontract awards. Duke has a track record of collaborating with various partners to deliver these services to government clients.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 12 | Funding Only Action | ($55k) | 2/6/12 | |
| 11 | Funding Only Action | $75.0k | 8/28/09 | |
| 10 | Other Administrative Action | $0 | 5/29/09 | |
| 9 | Supplemental Agreement for work within scope | $170.0k | 4/23/09 | |
| 8 | Funding Only Action | $345.6k | 9/8/08 |